Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Oliver & Co who wrote (3739)	2/5/1998 12:48:00 AM
From: Peter Singleton	of 6136

JLL, Izzy, You guys are both in the field. What's your opinion of Fortovase? JLL, besides the fact many patients have been exposed to SQV ... what about for new patients? Is the number of pills a material issue? How about tolerability ... it looks about the same as Viracept, and better than Crix and Norvir. Am I right on this? What about cross resistance? Any other issues? I'd sure feel more comfortable as an AGPH shareholder if you guys could give me a credible argument from the point of view of a prescribing physician why you feel Viracept remains the class of the field ... : ) but either way, I'd appreciate your opinion. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next